KIN - Kindred Biosciences, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5306.24M
Enterprise Value 3225.26M
Trailing P/E N/A
Forward P/E 1-6.27
PEG Ratio (5 yr expected) 1-0.12
Price/Sales (ttm)82.39
Price/Book (mrq)2.82
Enterprise Value/Revenue 360.60
Enterprise Value/EBITDA 6-3.78

Trading Information

Stock Price History

Beta (3Y Monthly) 0.19
52-Week Change 3-42.85%
S&P500 52-Week Change 38.28%
52 Week High 315.11
52 Week Low 35.96
50-Day Moving Average 37.14
200-Day Moving Average 37.86

Share Statistics

Avg Vol (3 month) 3165.51k
Avg Vol (10 day) 395.15k
Shares Outstanding 539.06M
Float 30.03M
% Held by Insiders 15.87%
% Held by Institutions 157.25%
Shares Short (Sep. 30, 2019) 4930.29k
Short Ratio (Sep. 30, 2019) 46.67
Short % of Float (Sep. 30, 2019) 43.11%
Short % of Shares Outstanding (Sep. 30, 2019) 42.38%
Shares Short (prior month Aug. 30, 2019) 4815.26k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 31, 2018
Most Recent Quarter (mrq)Jun. 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,635.19%

Management Effectiveness

Return on Assets (ttm)-31.76%
Return on Equity (ttm)-52.49%

Income Statement

Revenue (ttm)3.72M
Revenue Per Share (ttm)0.10
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)1.64M
EBITDA -59.62M
Net Income Avi to Common (ttm)-58.84M
Diluted EPS (ttm)-1.63
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)79.58M
Total Cash Per Share (mrq)2.04
Total Debt (mrq)1.73M
Total Debt/Equity (mrq)1.59
Current Ratio (mrq)11.36
Book Value Per Share (mrq)2.78

Cash Flow Statement

Operating Cash Flow (ttm)-56.99M
Levered Free Cash Flow (ttm)-52.52M